Evaluating the Communication Between Patients and Providers in Cancer Clinics
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- В протоколе указаны: TrialTalk™.
- Кому может быть актуально
- Состояния в реестре: Cancer. Базовые параметры: от 18 лет · Все.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- США
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Официальное название
Evaluating the Impact of TrialTalkTM; to Foster Equitable Cancer Care
Обзор
This clinical trial seeks to understand patients' experiences with the healthcare team and the quality of communication between patients and doctors in cancer clinics. The main question it aims to answer is: * Does TrialTalk™ improve communication between providers and patients? Participants will complete questionnaires before and after their standard of care clinic visit.
Подробное описание
The online TrialTalk™ training system uses evidence-based principles and best practices for instructional design for adult learners. The system uses a four-stage learning goal framework (i.e., knowledge, skill, understanding, and application) to ensure that the training moves from rote knowledge- and skill acquisition to integration, application, ownership, and long-term memory in clinical practice. The first module introduces the TrialTalk™ framework, why it's relevant and effective to patients and providers and describes the learning goals for the rest of the course. The second module focuses on essential elements of the TrialTalk™ conversation process through examples, metaphors, and description, followed by exercises at the end of the module that solidify the basic concepts of the conversational process. The third module focuses on the essential components of the diagram, how it integrates with the conversational process, and how to use it in a patient meeting. A set of assessment and reflection questions at the end of module 3 reinforces the concepts and components of the diagram. The fourth module brings all the TrialTalk™ elements together through case studies that exemplify how the conversational process and diagram work together in different types of patient meetings (for example, a new patient versus an established patient). Assessment and reflection questions at the end of module 4 focus on integrating and using the TrialTalk™ method in practice. Learners also develop a three-day action plan to begin to use TrialTalk™ with their patients. The TrialTalk™ training system provides learning resources to physicians such as a self-assessment rubric, FAQs, a checklist, and diagram template.
TrialTalk™ intervention includes two components: provider-focused skills-based training to ensure providers' competency in using the conversational and diagrammatic aspects of TrialTalk™, and the patient-facing component, which is the TrialTalk™ tool itself, to help patients understand their prognosis and treatment options in order to make a shared informed decision about their cancer management.
Вмешательства
- Другое TrialTalk™
TrialTalk™ is a communication tool that focuses on making the options visible and accessible while involving patients in the discussion.
Первичные конечные точки
- Fidelity - Providers [Срок оценки: Monthly for 6 months]
- Sustainability of TrialTalk™ communication tool [Срок оценки: 1 year]
- Change in quality of communication [Срок оценки: Up to 2 hours]
- Change in trust of provider [Срок оценки: Up to 2 hours]
- Usefulness of tool [Срок оценки: Up to 2 hours]
- Understanding of treatment options [Срок оценки: Up to 2 hours]
Критерии участия
Inclusion Criteria - Providers:
- Hematologists, medical oncologists, or hematology/oncology fellows
- Willing to complete TrialTalk™ training
Inclusion Criteria - Patients:
- ≥ 18 years old
- have a confirmed diagnosis of cancer
- identify as Black, African American, or non-Hispanic White
- can read and understand English to complete the study questionnaires
- had previous visits with the enrolled provider
Exclusion Criteria - Providers:
- providers who received previous training in the TrialTalk™ method or used it in practice before will be excluded
Exclusion Criteria - Patients:
\- have moderate to severe cognitive impairment as determined by participant's provider
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Нет
Дизайн исследования
- Распределение
- Нерандомизированное
- Модель
- Параллельные группы
- Маскирование
- Открытое
- Основная цель
- Организация здравоохранения
Центры проведения
США · 3 центра
- Northwestern Memorial Hospital — Chicago
- Medical University of South Carolina — Charleston
- University of Wisconsin - Madison — Madison
Идентификаторы
NCT: NCT06985953 · 2025-0274 · A534260 · SMPH/MEDICINE/HEM-ONC · UW24152